<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>1147</ReferenceId>
        <DateLastUpdated>2016-11-03-07:00</DateLastUpdated>
        <Article>
            <PubmedId>9741848</PubmedId>
            <Abstract>The crystal structures of class I major histocompatibility complex (MHC) molecules complexed with antigenic peptides revealed a network of hydrogen bonds between the charged amino- and carboxyl-termini of the peptides and conserved MHC residues at both ends of the peptide binding site. These interactions were shown to contribute substantially to the stability of class I MHC/peptide complexes by thermal denaturation studies using synthetic peptides in which either the amino- or carboxyl-terminal group is substituted by a methyl group. Here we report crystal structures of HLA-A*0201 complexed with these terminally modified synthetic peptides showing that they adopt the same bound conformation as antigenic peptides. A number of variations in peptide conformation were observed for the terminally modified peptides, including in one case, a large conformational difference in four central peptide residues that is apparently caused by the lattice contact. This is reminiscent of the way binding a T-cell receptor changed the conformation of central residues of an MHC-bound peptide. The structures determined identify which conserved hydrogen bonds are eliminated in terminally substituted peptides and suggest an increased energetic importance of the interactions at the peptide termini for MHC-peptide stability.</Abstract>
            <ArticleYear>1998</ArticleYear>
            <ArticlePages>97-106</ArticlePages>
            <ArticleTitle>Crystal structures of HLA-A*0201 complexed with antigenic peptides with either the amino- or carboxyl-terminal group substituted by a methyl group.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Bouvier</LastName>
                    <ForeName>M</ForeName>
                </Author>
                <Author>
                    <LastName>Guo</LastName>
                    <ForeName>H C</ForeName>
                </Author>
                <Author>
                    <LastName>Smith</LastName>
                    <ForeName>K J</ForeName>
                </Author>
                <Author>
                    <LastName>Wiley</LastName>
                    <ForeName>D C</ForeName>
                </Author>
            </Authors>
            <Affiliations>Department of Molecular and Cellular Biology, Howard Hughes Medical Institute, Harvard University, Cambridge, Massachusetts 02138, USA.</Affiliations>
            <ArticleChemicalList>HLA-A2 Antigen;M-protein, influenza virus;Peptides;Viral Matrix Proteins</ArticleChemicalList>
            <ArticleMeshHeadingsList>Crystallography, X-Ray; HLA-A2 Antigen(chemistry; immunology); Humans; Influenza A virus(chemistry); Peptides(chemical synthesis; chemistry; immunology); Protein Conformation; Viral Matrix Proteins(chemical synthesis; chemistry; immunology)</ArticleMeshHeadingsList>
            <Journal>
                <Volume>33</Volume>
                <Issue>1</Issue>
                <Title>Proteins</Title>
                <Issn>1097-0134</Issn>
                <MedlineTa>Proteins</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>V9-Cdel</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>GILGFVFTL</LinearSequence>
                        <ModifiedResidues>L9</ModifiedResidues>
                        <Modifications>1,2-dimethylpropylamine</Modifications>
                        <StartingPosition>58</StartingPosition>
                        <EndingPosition>66</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P35937.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11320</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table I</LocationOfData>
                <EpitopeId>20351</EpitopeId>
                <ReferenceStartingPosition>58</ReferenceStartingPosition>
                <ReferenceEndingPosition>66</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The epitope is from influenza virus matrix protein M1, peptide 58-66, with L9 substituted by a methyl group, 1,2-dimethylpropylamine,  NHCH(CH(CH3)2)CH3.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table I</LocationOfData>
                        <MhcBindingId>1778388</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>261</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>44.0</QuantitativeMeasurement>
                            <AssayComments>Modification of the C-terminal residue reduced the thermal denaturation temperature to 44.0 C compared to 64.9 C for the unmodified epitope/HLA-A*0201 complex.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>143</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Tables II, III, Figures 2, 4, and PDB 1B0R</LocationOfData>
                        <MhcBindingId>15937</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>175</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>2.9</QuantitativeMeasurement>
                            <MeasurementInequality>=</MeasurementInequality>
                            <AssayComments>No interpretable electron density was observed at the P4-Gly and P5-Phe positions of the peptide.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>143</MhcAlleleId>
                        <ThreeDimensionalStructureOfComplex>
                            <ComplexPdbId>1B0R</ComplexPdbId>
                            <MhcChain1PdbChain>A</MhcChain1PdbChain>
                            <MhcChain2PdbChain>B</MhcChain2PdbChain>
                            <EpitopePdbChain>C</EpitopePdbChain>
                            <EpitopeResidues>C: G701, I702, L703, V706, F707, T708, (CDE)709;</EpitopeResidues>
                            <ViewerFlag>Y</ViewerFlag>
                            <Comments>The bound conformation of the peptide is similar to that of the matrix peptide. A crystal lattice contact occurs between the C-terminal of the HLA-A2 heavy chain (Glu275) and positions P6 and P7 of the peptide.</Comments>
                            <CuratedContacts>
                                <EpitopeResidues>C: G701, I702, L703, V706, F707, T708, (CDE)709;</EpitopeResidues>
                                <EpitopeResiduesInteractingWithMhc>C: ;</EpitopeResiduesInteractingWithMhc>
                                <MhcResiduesInteractingWithEpitope>A: ;</MhcResiduesInteractingWithEpitope>
                            </CuratedContacts>
                            <CalculatedContacts>
                                <EpitopeResiduesInteractingWithMhc>C: G701, I702, L703, V706, F707, T708, (CDE)709;</EpitopeResiduesInteractingWithMhc>
                                <MhcResiduesInteractingWithEpitope>A: M5, Y7, F9, E63, K66, V67, H70, T73, D77, L81, R97, Y99, H114, Y116, Y123, T143, W147, V152, Q155, Y159, W167, Y171</MhcResiduesInteractingWithEpitope>
                                <ContactAreaForEpitope>946.2</ContactAreaForEpitope>
                                <ContactAreaForMhc>533.5</ContactAreaForMhc>
                            </CalculatedContacts>
                        </ThreeDimensionalStructureOfComplex>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>L9A</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>GILGFVFTA</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is an analog of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>GILGFVFTL</LinearSequence>
                            <StartingPosition>58</StartingPosition>
                            <EndingPosition>66</EndingPosition>
                            <SourceMolecule>
                                <GenBankId>P35937.1</GenBankId>
                            </SourceMolecule>
                            <SourceOrganismId>11320</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <LocationOfData>Table I</LocationOfData>
                <EpitopeId>20342</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table I</LocationOfData>
                        <MhcBindingId>1779826</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>261</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>65.9</QuantitativeMeasurement>
                            <AssayComments>Alanine substitution of the C-terminal residue did not affect the thermal denaturation temperature compared to the natural matrix peptide (GILGFVFTL)/HLA-A*0201 complex (Tm = 64.9 C).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>143</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Tables II, III, and Figure 2</LocationOfData>
                        <MhcBindingId>1779816</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>175</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>2.5</QuantitativeMeasurement>
                            <MeasurementInequality>=</MeasurementInequality>
                        </AssayInformation>
                        <MhcAlleleId>143</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>G1-Ndel</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>GILGFVFTA</LinearSequence>
                        <ModifiedResidues>G1</ModifiedResidues>
                        <Modifications>Methylation|METH</Modifications>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is an analog of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>GILGFVFTL</LinearSequence>
                            <StartingPosition>58</StartingPosition>
                            <EndingPosition>66</EndingPosition>
                            <SourceMolecule>
                                <GenBankId>P35937.1</GenBankId>
                            </SourceMolecule>
                            <SourceOrganismId>11320</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <LocationOfData>Table I</LocationOfData>
                <EpitopeId>133583</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The amino terminal residue was substituted by a methyl group CH&lt;sub&gt;3&lt;/sub&gt;CH&lt;sub&gt;2&lt;/sub&gt;CO.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table I</LocationOfData>
                        <MhcBindingId>1779827</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>261</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>44.9</QuantitativeMeasurement>
                            <AssayComments>Modification of the N-terminal residue reduced the thermal denaturation temperature of the epitope/HLA-A*0201 complex to 44.9 C compared to 64.9 C for the wild type M1 peptide (GILGFVFTL)/HLA-A*0201 complex.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>143</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Tables II, III, and Figure 2</LocationOfData>
                        <MhcBindingId>1779817</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>175</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>2.6</QuantitativeMeasurement>
                            <MeasurementInequality>=</MeasurementInequality>
                        </AssayInformation>
                        <MhcAlleleId>143</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>A9-Cdel</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>GILGFVFTA</LinearSequence>
                        <ModifiedResidues>A9</ModifiedResidues>
                        <Modifications>Methylation|METH</Modifications>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is an analog of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>GILGFVFTL</LinearSequence>
                            <StartingPosition>58</StartingPosition>
                            <EndingPosition>66</EndingPosition>
                            <SourceMolecule>
                                <GenBankId>P35937.1</GenBankId>
                            </SourceMolecule>
                            <SourceOrganismId>11320</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <LocationOfData>Table I</LocationOfData>
                <EpitopeId>133582</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The carboxy terminal residue was substituted by a methyl group NHCH(CH&lt;sub&gt;3&lt;/sub&gt;)&lt;sub&gt;2&lt;/sub&gt;.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table I</LocationOfData>
                        <MhcBindingId>1779828</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>261</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>42.8</QuantitativeMeasurement>
                            <AssayComments>Modification of the C-terminal residue reduced the thermal denaturation temperature of the epitope/HLA-A*0201 complex to 42.8 C compared to 64.9 C for the wild type M1 peptide (GILGFVFTL)/HLA-A*0201 complex.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>143</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Tables II, III, and Figure 2</LocationOfData>
                        <MhcBindingId>1779820</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>175</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>2.5</QuantitativeMeasurement>
                            <MeasurementInequality>=</MeasurementInequality>
                        </AssayInformation>
                        <MhcAlleleId>143</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

